Medicine recalls
|
| |
| Batch recall of Seirogan Toi A Sugar Coated Tablet |
| |
The Department of Health (DH) today (Oct 4) endorsed a licensed drug wholesaler, Taiko Pharmaceutical (Asia Pacific) Co., Limited (Taiko), to recall a batch (batch number: 41QC1) of Seirogan Toi A Sugar Coated Tablet (Hong Kong registration number: HK-19878) from the market due to potential quality issue.
The DH received notification from Taiko that the overseas manufacturer of the product is recalling the above batch because there was deviation noted in the preparation method of one of the product's active ingredient, i.e. Phellodendron bark dried extract, from the supplier. Although the product's manufacturer confirmed that the product has passed all tests during release, the affected batch is voluntarily recalled as a precautionary measure.
The above product, containing Phellodendron bark dried extract, creosote and geranium herb, is an over-the-counter medicine indicated for relief of occasional diarrhea. According to Taiko, the above batch of product has been supplied to local pharmacies, medicine stores and re-exported to Macau.
Taiko has set up a hotline (2907 7300) to answer related enquiries.
So far, the DH has not received any adverse drug reaction report related to the affected batch of product. The DH will closely monitor the recall.
Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product.
Ends/Wednesday, Oct 4, 2023
|
| |
|
